These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1832065)

  • 1. The effects of thromboxane receptor antagonists on oestrogen-induced uterotrophic responses in the spontaneously hypertensive rat.
    Kerr MB; Marshall K; Senior J
    Br J Pharmacol; 1991 Jun; 103(2):1363-6. PubMed ID: 1832065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modification of the rat uterine response to oestrogen and tamoxifen by thromboxane antagonists.
    Kerr MB; Marshall K; Senior J
    Br J Pharmacol; 1991 Mar; 102(3):742-6. PubMed ID: 1364847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of thromboxane in the uterotrophic response in the gravid normotensive and spontaneously hypertensive rat.
    Kerr MB; Marshall K; Senior J
    J Endocrinol; 1992 Nov; 135(2):257-61. PubMed ID: 1474332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of contraction-mediating prostanoid receptors in human hand veins: effects of the thromboxane receptor antagonists BM13,505 and AH23848.
    Arner M; Högestätt ED; Uski TK
    Acta Physiol Scand; 1991 Jan; 141(1):79-86. PubMed ID: 2053448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of mepyramine and ranitidine on the oestrogen and anti-oestrogen stimulated rat uterus.
    Marshall K; Senior J
    Br J Pharmacol; 1986 Sep; 89(1):251-6. PubMed ID: 3801774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study on the effect of a single dose of tamoxifen on uterine hyperaemia and growth in the rat.
    Marshall K; Senior J
    Br J Pharmacol; 1987 Oct; 92(2):429-35. PubMed ID: 3676603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of a single dose of oestradiol on tamoxifen-induced uterine hyperaemia and growth in the rat.
    Marshall K; Senior J
    Br J Pharmacol; 1989 Oct; 98(2):383-8. PubMed ID: 2819325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GR32191, a highly potent and specific thromboxane A2 receptor blocking drug on platelets and vascular and airways smooth muscle in vitro.
    Lumley P; White BP; Humphrey PP
    Br J Pharmacol; 1989 Jul; 97(3):783-94. PubMed ID: 2527074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of endogenous thromboxane in contractions to U46619, oxygen, 5-HT and 5-CT in the human isolated umbilical artery.
    Templeton AG; McGrath JC; Whittle MJ
    Br J Pharmacol; 1991 May; 103(1):1079-84. PubMed ID: 1878747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interspecies differences in thromboxane receptors: studies with thromboxane receptor antagonists in rat and guinea pig smooth muscles.
    Ogletree ML; Allen GT
    J Pharmacol Exp Ther; 1992 Feb; 260(2):789-94. PubMed ID: 1531361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the uterotrophic response in cyclic and ovariectomized normotensive and spontaneously hypertensive rats.
    Kerr MB; Marshall K; Senior J
    J Endocrinol; 1992 Nov; 135(2):263-9. PubMed ID: 1474333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Competitive antagonism at thromboxane receptors in human platelets.
    Armstrong RA; Jones RL; Peesapati V; Will SG; Wilson NH
    Br J Pharmacol; 1985 Mar; 84(3):595-607. PubMed ID: 2580580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BAY u3405, a potent and selective thromboxane A2 receptor antagonist on airway smooth muscle in vitro.
    McKenniff MG; Norman P; Cuthbert NJ; Gardiner PJ
    Br J Pharmacol; 1991 Nov; 104(3):585-90. PubMed ID: 1839139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the thromboxane-receptor antagonists AH 23848 and BM 13.177 on human uteroplacental arteries.
    Svane D; Skajaa K; Andersson KE; Forman A
    Obstet Gynecol; 1992 Aug; 80(2):234-40. PubMed ID: 1386150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for homogeneity of thromboxane A2 receptor using structurally different antagonists.
    Swayne GT; Maguire J; Dolan J; Raval P; Dane G; Greener M; Owen DA
    Eur J Pharmacol; 1988 Aug; 152(3):311-9. PubMed ID: 2975605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of thromboxane receptor antagonists on venous thrombosis in rats.
    Schumacher WA; Heran CL
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1109-15. PubMed ID: 2522985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity of prostaglandin H2/thromboxane A2 receptors: distinct subtypes mediate vascular smooth muscle contraction and platelet aggregation.
    Furci L; Fitzgerald DJ; Fitzgerald GA
    J Pharmacol Exp Ther; 1991 Jul; 258(1):74-81. PubMed ID: 1830100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of Bay U 3405, a novel thromboxane A2/endoperoxide receptor antagonist.
    Perzborn E; Fiedler VB; Seuter F; Stasch JP; Weber H; Sander E; Böshagen H; Rosentreter U
    Stroke; 1990 Dec; 21(12 Suppl):IV143-5. PubMed ID: 2148034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thromboxane A2 receptor antagonists.
    Hall SE
    Med Res Rev; 1991 Sep; 11(5):503-79. PubMed ID: 1834898
    [No Abstract]   [Full Text] [Related]  

  • 20. AH23848: a thromboxane receptor-blocking drug that can clarify the pathophysiologic role of thromboxane A2.
    Brittain RT; Boutal L; Carter MC; Coleman RA; Collington EW; Geisow HP; Hallett P; Hornby EJ; Humphrey PP; Jack D
    Circulation; 1985 Dec; 72(6):1208-18. PubMed ID: 2998642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.